
North America dominated the Arthralgia Drugs Market with the largest revenue share of 38.42% in 2025, supported by a high prevalence of arthritis-related disorders, advanced healthcare infrastructure, and strong adoption of innovative pain management therapies.
The Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) segment led the market with a 39.87% share in 2025, driven by their widespread use as first-line therapy for managing joint pain and inflammation associated with osteoarthritis, rheumatoid arthritis, and other musculoskeletal disorders
Asia-Pacific is expected to be the fastest-growing region at a CAGR of 7.4% from 2026 to 2033, fueled by a rapidly aging population, improving healthcare access, and increasing diagnosis rates of musculoskeletal disorders across China, India, and Japan.
Corticosteroids are the fastest-growing drug type, projected to register a CAGR of 7.1%, reflecting the surge in use in patients with severe inflammatory joint conditions requiring rapid symptom control.
The Tablets segment dominated the dosage form category with a 48.64% revenue share in 2025, led by their convenience, ease of administration, and widespread patient preference for long-term pain management.


Nice breakdown! The smaller details are easy to overlook before launch. I've also seen people discussing Mirror of Kalandra, but I'll wait until the game is released before looking into it further.